|
Wednesday 9th December 2009 |
Text too small? |
BioVittoria, the Hamilton-based biotechnology firm, pushed out the closing date for its initial public offering after financial advisers asked for more time to sell the investment, making it the third float in a month to hit speed wobbles.
The company, which is looking to tap new investors on the stock exchange for some $20 million to commercialise a sweetener extract, extended it closing date to December 29 from December 11.
That's the second delay for the sale originally slated to close November 25. In a statement to the NZX, BioVittoria said it’s “moving towards its minimum subscription level” of $8 million, but competing offers had left investors with too many options and its advisers “indicated that they require further time because of the relatively unique nature of BioVittoria as an investment.”
“It is late in the year and I wouldn’t expect to see any more” offers to the market, said Stephen Walker, head of asset management at Goldman Sachs JBWere. “It would be nice to have them spaced out a bit – if you have to get the funds for several offers at the same time, it becomes quite a tall order.”
BioVittoria joins property investor DNZ Property Fund and dairy company Synlait Milk to have their plans to list on the stock exchange hit some troubles after resurgent markets gave companies the confidence to consider public offerings again. DNZ had the money prepared, but shareholder MMG declined to support the deal, while Synlait struggled to secure investor support.
Walker said there was still an appetite for new opportunities, and that the wobbles in these offerings had occurred for “quite different reasons.”
Investors have been flush with opportunities in recent months, with offerings from the listing of discount outdoor equipment retailer Kathmandu Holdings, a new prospectus from South Canterbury Finance, and bonds issued by Auckland International Airport and the University of Canterbury.
“We’d all like to see other opportunities, particularly in companies where there’s some good growth,” Walker said.
Businesswire.co.nz
No comments yet
IKE - FY26 Financial Results
Chorus submits 2025 fibre regulatory report
SPG - FY26 Annual Results
PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026
PEB - Advancing Medicare Coverage Goals; Cost Contained